An innovative hub of pharmaceutical manufacturers
Companies from the pharmaceutical industry benefit from an excellent research and clinical landscape in Berlin as a pharmaceutical location.
The sustainable success of the pharmaceuticals industry in Berlin-Brandenburg is based on a history of innovative products going back to the 19th century. The industry benefits from an excellent scientific and clinical environment as well as proximity to the decision-makers of the German health care system.
The geographical location of the German capital region enables good access to Western, Central and Eastern European markets. Global players such as Bayer, Berlin-Chemie (Menarini), Daiichi Sankyo, Pfizer, Bausch + Lomb, Sanofi and Takeda as well as more than 20 medium-sized pharmaceutical companies are based in Berlin-Brandenburg. They employ around 12,300 people.
The industry benefits from
- an excellent scientific and clinical environment
- the biotech expertise in the region
- proximity to the decision-makers for the German healthcare system
- the central geographical location of the German capital region with good access to Western, Central, and Eastern European markets
- the close connection between research, development, and clinical practice
- well established translational research
- excellent infrastructure for technology transfer
- numerous options for clinical trials
With a large and diverse patient population and 145 hospitals, the Berlin-Brandenburg region makes all types of clinical research projects possible.
Why Berlin?
„The Berlin-Brandenburg metropolitan area is a unique place inside the German healthcare sector. Nowhere else in Germany will you find a comparable concentration of world class science, hospitals and industry. This cross-functional cluster turns the German capital region into a true magnet for healthcare investments in Europe.“
President Pharmaceuticals
Bayer AG
#1 site for clinical trials in Germany
Berlin leads the list of cities in Germany with a high number of students by a wide margin. This is the result of a survey by the industry association vfa based on the clinicaltrials.gov study registry (as of: 2022).
Pharmaceutical companies in the capital region
There are currently approx. 35 pharmaceuticals companies in the capital region.
